Dr. Shields is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1865 Lime St
Ste 101
Amelia Island, FL 32034
Summary
- Board-Certified Physician with over 30 years clinical experience in pain management, anesthesiology and emergency medicine in the community hospital setting. Leadership history in practice management, utilization management and quality improvement activities in the hospital and managed care setting. Experienced in telemedicine. Certified Health Coach.
Education & Training
- Stony Brook Medicine/University HospitalResidency, Anesthesiology, 1983 - 1985
- Conemaugh Memorial Medical CenterInternship, Transitional Year, 1982 - 1983
- University of Mississippi School of MedicineClass of 1982
Certifications & Licensure
- NY State Medical License 1984 - Present
- FL State Medical License 2017 - 2026
- GA State Medical License 1985 - 2025
- NC State Medical License 1987 - 1988
- WV State Medical License 1983 - 1985
- PA State Medical License 1982 - 1983
- American Board of Anesthesiology Anesthesiology
- American Board of Pain Medicine Pain Medicine
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification AllMeds EHR, AllMeds, Inc., 2011-2012
Research History
- InvestigatorAXS-07 is an oral, investigational medicine consisting of MoSEIC meloxicam and rizatriptan, which is being developed for the acute treatment of migraine with or without aura in adults.2019 - 2020
- Unblinded Treatment Administration InvestigatorCorticosteroid Lumbar Epidural Analgesia for Radiculopathy (C.L.E.A.R.). Evaluation of the analgesic effect on average leg pain (as measured by the numeric pain rating scale [NPRS] in the affected leg) following a single transforaminal (TF) injection of SP-102 compared to IM injection of placebo.2018 - 2020
- InvestigatorA prospective, multicenter, randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of a single injection of rexlemestrocel - alone or combined with hyaluronic acid (ha) in subjects with chronic low back pain (MSB-DR003).2017 - 2020
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: